Companies in #Acute Coronary Syndrome

Found 1 company operating in this sector.

CeleCor Therapeutics

Private

Clinical-stage biotechnology company developing pre-hospital therapies for heart attacks, led by zalunfiban (RUC-4), an investigational subcutaneous GPIIb/IIIa platelet inhibitor designed for first-medical-contact treatment of STEMI.

Sector:Cardiovascular

HQ:Del Mar, California, USA

View Profile →